Selective mutism
Selective mutism is a complex childhood anxiety disorder characterized by a child's inability to speak and communicate effectively in select social settings, such as school. These children are able to speak and communicate in settings where they are comfortable, secure, and relaxed.
Etiology
Selective mutism is believed to be a psychosocial disorder that results from anxiety, specifically social anxiety, that causes the child to be unable to speak in certain situations. It is not a form of stubbornness or defiance. It is also not a result of trauma or a developmental disorder.
Symptoms
Children with selective mutism often exhibit the following symptoms:
- Consistent failure to speak in specific social situations where there is an expectation for speaking (e.g., at school)
- The disturbance interferes with educational or occupational achievement or with social communication
- The duration of the disturbance is at least 1 month (not limited to the first month of school)
- Failure to speak is not due to a lack of knowledge of, or comfort with, the spoken language required in the social situation
- The disturbance is not better accounted for by a communication disorder (e.g., stuttering) and does not occur exclusively during a Pervasive Developmental Disorder, Schizophrenia, or other psychotic disorder.
Diagnosis
Selective mutism is diagnosed based on specific criteria outlined in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). A comprehensive evaluation should be conducted by a mental health professional who is knowledgeable about this disorder.
Treatment
Treatment for selective mutism involves a multidisciplinary approach that includes the child, family, school professionals, and mental health professionals. Treatment options include behavioral therapy, cognitive behavioral therapy, play therapy, and family therapy. Medication may also be used in conjunction with therapy.
See also
References
<references />
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


